Search result for 'p-cab'

Dr Reddy's Laboratories has inked a licensing deal with Takeda Pharmaceutical to commercialize Vonoprazan tablets in India, a novel treatment for reflux esophagitis and other acid peptic disorders.

Zydus Lifesciences has signed a licensing deal with Takeda to market Vonoprazan, a P-CAB drug for GERD, in India under the brand name Vault.

Sun Pharma has partnered with Takeda to bring Vonoprazan, a novel gastrointestinal drug, to the Indian market. This partnership aims to provide patients with a new treatment option for reflux...

Torrent Pharmaceuticals has licensed Vonoprazan, a novel P-CAB for GERD treatment, from Takeda. The drug will be marketed in India under the brand name Kabvie.